Per Bergström

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text

Medicine, Oncology, Pharmacology +15

SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC

Jan Nyman, Andreas Hallqvist, Jo‐Åsmund Lund et al. · Radiotherapy and Oncology · 2016 · 344 citations · Full text

Medicine, Oncology, Radiation Oncology +16

The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy

Karin Lindberg, Vitali Grozman, Kristin Karlsson et al. · Journal of Thoracic Oncology · 2021 · 206 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma

David A. Reardon, G. Dresemann, Sophie Taillibert et al. · British Journal of Cancer · 2009 · 130 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

OA24.05 The Nordic HILUS-Trial - First Report of a Phase II Trial of SBRT of Centrally Located Lung Tumors

Karin Lindberg, Per Bergström, Odd Terje Brustugun et al. · Journal of Thoracic Oncology · 2017 · 45 citations · Full text

Medicine, Oncology, Surgery +10